Firefly Neuroscience Inc
AIFF
View Detailed Chart
3.040USD
+0.090+3.05%
Close 10/06, 16:00（ET）Quotes delayed by 15 min
40.43MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.05%
5 Days
+4.83%
1 Month
+9.35%
6 Months
-9.52%
Year to Date
+14.72%
1 Year
+3.05%
View Detailed Chart
TradingKey Stock Score of Firefly Neuroscience Inc
Currency: USD Updated: 2025-10-06Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a good stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Firefly Neuroscience Inc's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Firefly Neuroscience Inc Highlights
StrengthsRisks
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Growing
The company is in a growing phase, with the latest annual income totaling USD 108.00K.
Fairly Valued
The company’s latest PE is -1.07, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.45M shares, increasing 40.21% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 101.99K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.22.
Financial Indicators
EPS
No Data
Total revenue
No Data
Firefly Neuroscience Inc Info
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Ticker SymbolAIFF
CompanyFirefly Neuroscience Inc
CEOMr. Greg Lipschitz
Websitehttps://fireflyneuro.com/
Related Instruments
+0.36%
+2.25%
+1.16%
-0.26%
0.00%
+3.16%
+2.01%
+2.83%
+0.39%
+0.21%
+1.53%
+1.26%
-0.81%
-0.65%
-0.60%
-2.44%
-0.30%
+1.62%
+1.24%
+0.28%Popular Symbols
